Southern Illinois University School of Medicine
Springfield, Illinois, 62794-9636, United States
NCT Number: NCT00640666
It is important to confirm health benefits experienced by breast cancer survivors after participation in a physical activity behavior change intervention. One such potential benefit is a reduction in harmful inflammation that might lead to increased symptoms or cancer risk. Because little is known about how physical activity behavior change interventions influence inflammation in breast cancer survivors, the investigators study will measure inflammation with blood markers known as cytokines among breast cancer survivors before and after a physical activity intervention. Such information has the potential to lead to improved physical functioning, reduction in bothersome symptoms (e.g., fatigue), and reduced cancer risk in breast cancer survivors.
Looking for future studies?
Notify Me18 year–70 year
Female
Interventional
Not applicable
Springfield, Illinois, 62794-9636, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Multidisciplinary
Other names: physical activity, exercise
Time frame: baseline and 3 months
Time frame: baseline and 3 months
University of Alabama at Birmingham
Other
Acronym: CICK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04000880
Adnexal Diseases, Behavior
Birmingham, Alabama, United States
View Trial DetailsNCT06340503
Behavior, Breast Cancer
Winston-Salem, North Carolina, United States
View Trial DetailsNCT06791018
Behavior, Breast Cancer
Edmonton, Alberta, Canada
View Trial DetailsNCT05297773
Behavior, Breast Cancer
Lisbon, Cruz-Quebrada, Portugal
View Trial Details